Abstract
Chitosan-based carriers have coined their position as delivery agents. When assembled with polyanions into nanogels (NG), these vectors have enabled the delivery of drugs, genes, and proteins to a myriad of applications. However, the chemical and colloidal instability of chitosan nanoformulations in physiologically compatible media prejudices in vitro biocompatibility and, thus, scale-up applications. To overcome this issue, we envisaged the coating of chitosan nanogel with phospholipids. In this investigation, we report a two-stage synthesis of hybrid lipid-coated chitosan nanogels, named nanolipogels (NLG), to improve colloidal stability and in vitro biocompatibility over chitosan NG. Practically, we employed a mixing platform to first prepare chitosan NG by ionic gelation, dilute the suspension, and, in a second stage, coat the NG with lipids. We demonstrate that lipid coating increased particle size and reversed the ζ-potential to negative values, suggesting the successful formation of NLG, while maintaining a homogeneous size distribution (PDI < 0.25). Furthermore, multiple light scattering analysis confirmed NLG improved colloidal stability in phosphate buffer saline and cell culture medium, with respect to NG. Finally, lipid coating completely abrogated the cytotoxicity of NG when incubated at 50 μg·mL−1 with HeLa, U87, or b.End3 cell lines and significantly improved the biocompatibility at 100 and 150 μg·mL−1. Future investigations will explore how the lipid coating affects drug loading, release profile, and the ability of NLG to deliver drugs and genes in vitro.
References
Shariatinia Z. Pharmaceutical applications of chitosan. Adv Colloid Interf Sci. 2019;263:131–94.
Garcia-Fuentes M, Alonso MJ. Chitosan-based drug nanocarriers: where do we stand? J Control Release. 2012;161(2):496–504.
Ozturk K, Arslan FB, Tavukcuoglu E, Esendagli G, Calis S. Aggregation of chitosan nanoparticles in cell culture: reasons and resolutions. Int J Pharm. 2020;578:119119.
Nafee N, Schneider M, Schaefer UF, Lehr C-M. Relevance of the colloidal stability of chitosan/PLGA nanoparticles on their cytotoxicity profile. Int J Pharm. 2009;381(2):130–9.
Bugnicourt L, Ladavière C. A close collaboration of chitosan with lipid colloidal carriers for drug delivery applications. J Control Release. 2017;256:121–40.
Li X, Guo S, Zhu C, Zhu Q, Gan Y, Rantanen J, et al. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles. Biomaterials. 2013;34(37):9678–87.
Diebold Y, Jarrín M, Sáez V, Carvalho ELS, Orea M, Calonge M, et al. Ocular drug delivery by liposome–chitosan nanoparticle complexes (LCS-NP). Biomaterials. 2007;28(8):1553–64.
Guo P, Liu D, Subramanyam K, Wang B, Yang J, Huang J, et al. Nanoparticle elasticity directs tumor uptake. Nat Commun. 2018;9(1):130.
Baghdan E, Pinnapireddy SR, Strehlow B, Engelhardt KH, Schäfer J, Bakowsky U. Lipid coated chitosan-DNA nanoparticles for enhanced gene delivery. Int J Pharm. 2018;535(1):473–9.
Callewaert M, Roullin VG, Cadiou C, Millart E, Van Gulik L, Andry MC, et al. Tuning the composition of biocompatible Gd nanohydrogels to achieve hypersensitive dual T1/T2 MRI contrast agents. J Mater Chem B. 2014;2(37):6397–405.
Courant T, Roullin VG, Cadiou C, Callewaert M, Andry MC, Portefaix C, et al. Hydrogels incorporating GdDOTA: towards highly efficient dual T1/T2 MRI contrast agents. Angew Chem Int Ed Eng. 2012;51(36):9119–22.
Jiang M, Gan L, Zhu C, Dong Y, Liu J, Gan Y. Cationic core–shell liponanoparticles for ocular gene delivery. Biomaterials. 2012;33(30):7621–30.
Chiesa E, Dorati R, Pisani S, Conti B, Bergamini G, Modena T, et al. The microfluidic technique and the manufacturing of polysaccharide nanoparticles. Pharmaceutics. 2018;10(4):267.
Hong JS, Stavis SM, DePaoli Lacerda SH, Locascio LE, Raghavan SR, Gaitan M. Microfluidic directed self-assembly of liposome-hydrogel hybrid nanoparticles. Langmuir. 2010;26(13):11581–8.
Valencia PM, Farokhzad OC, Karnik R, Langer R. Microfluidic technologies for accelerating the clinical translation of nanoparticles. Nat Nanotechnol. 2012;7(10):623–9.
Kulkarni JA, Thomson SB, Zaifman J, Leung J, Wagner PK, Hill A, et al. Spontaneous, solvent-free entrapment of siRNA within lipid nanoparticles. Nanoscale. 2020;12(47):23959–66.
Sun J, Zhang L, Wang J, Feng Q, Liu D, Yin Q, et al. Tunable rigidity of (polymeric core)-(lipid shell) nanoparticles for regulated cellular uptake. Adv Mater. 2015;27(8):1402–7.
Gan L, Wang J, Zhao Y, Chen D, Zhu C, Liu J, et al. Hyaluronan-modified core–shell liponanoparticles targeting CD44-positive retinal pigment epithelium cells via intravitreal injection. Biomaterials. 2013;34(24):5978–87.
Cardia MC, Caddeo C, Lai F, Fadda AM, Sinico C, Luhmer M. 1H NMR study of the interaction of trans-resveratrol with soybean phosphatidylcholine liposomes. Sci Rep. 2019;9(1):17736.
Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem. 1959;234(3):466–8.
Zhang L, Feng Q, Wang J, Sun J, Shi X, Jiang X. Microfluidic synthesis of rigid nanovesicles for hydrophilic reagents delivery. Angew Chem Int Ed Eng. 2015;54(13):3952–6.
Derbali RM, Aoun V, Moussa G, Frei G, Tehrani SF, Del’Orto JC, et al. Tailored nanocarriers for the pulmonary delivery of levofloxacin against pseudomonas aeruginosa: a comparative study. Mol Pharm. 2019;16:1906–16.
Calvo NL, Sreekumar S, Svetaz LA, Lamas MC, Moerschbacher BM, Leonardi D. Design and characterization of chitosan nanoformulations for the delivery of antifungal agents. Int J Mol Sci. 2019;20(15):3686.
Acknowledgements
The authors acknowledge financial support from National Sciences and Engineering Research Council (JLC grant # RGPIN-2018-05682; VGR grant # RGPIN/06636-2018). The MLS Nanobrook Omni DLS and TurbiscanLAB™ used in this study were acquired with funds from Canada Foundation for Innovation (VGR grant # #34227). VPG acknowledges the support of Mitacs Inc. (Mitacs Globalink Graduate Fellowship Award GLF407).
Author information
Authors and Affiliations
Contributions
Victor Passos Gibson: methodology, formal analysis, investigation, writing — original draft, and writing — review & editing; Julia Balestrero Braga Nunes: investigation; Deborah Quintanilha Falcão: conceptualization, methodology, and investigation; V. Gaëlle Roullin: conceptualization, resources, writing — review & editing, funding acquisition, and supervision; Jeanne Leblond Chain: conceptualization, resources, writing — review & editing, funding acquisition, and supervision.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Supplemental Information includes 1 table and 3 figures, the detailed materials and method section, as well as the data available in this study.
ESM 1
(DOCX 737 kb)
Rights and permissions
About this article
Cite this article
Passos Gibson, V., Nunes, J.B.B., Falcao, D.Q. et al. Lipid Coating of Chitosan Nanogels for Improved Colloidal Stability and In Vitro Biocompatibility. AAPS PharmSciTech 22, 159 (2021). https://doi.org/10.1208/s12249-021-02027-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/s12249-021-02027-5